In this study, we showed that FGF19 activates HSCs‐to‐CAFs differentiation, which aligns with the findings from other studies.[10] However, in patients with liver fibrosis, lower levels of FGF19 are associated with more severe hepatic fibrosis,[32] suggesting an antifibrotic effect of FGF19. The gene discussed is FGF19; the disease is Hepatic fibrosis.